Hallucinogens have shown promise for treating depression, anxiety and obsessive compulsive disorder. The gold standard for drug development is usually to test a treatment against a placebo. This overcomes the placebo effect, when someone’s medical symptoms are lessened through the power of suggestion and expectation. But in psychedelic research, people are often able to perceive whether they are in the dosing group.